MELVILLE, NY--(Marketwired - Sep 19, 2016) - FONAR Corporation (
- 22% Increase of Fiscal 2016 Diluted Net Income per Common Share available to Common Shareholders to $2.38, versus prior year
- 22% Increase of Fiscal 2016 Net Income to $18.8 million, versus prior year
- 11 % Increase of Fiscal 2016 Income from Operations to $14.4 million, versus prior year
- 6% Increase of Fiscal 2016 Net Revenues to $73.4 million, versus prior year
- Diluted Net Income per Common Share available to Common Shareholders for the Fiscal year ending June 30, 2016 was $2.38, including a $4.6 million impact of recorded income tax benefits
FONAR Corporation (
Financial Highlights
Net income increased 22% to $18.8 million for the fiscal year ended June 30, 2016. This compares to $15.4 million for the fiscal year ended June 30, 2015.
Income from operations increased 11% to $14.4 million for the fiscal year ended June 30, 2016. This compares to $12.9 million for the fiscal year ended June 30, 2015.
Basic net income per common share available to common shareholders increased 22% to $2.43 for the fiscal year ended June 30, 2016 as compared to $2.00 for the fiscal year ended June 30, 2015.
Diluted net income per common share available to common shareholders increased 22% to $2.38 for the fiscal year ended June 30, 2016 as compared to $1.95 for the fiscal year ended June 30, 2015.
Net revenues increased 6% to $73.4 million for the fiscal year ended June 30, 2016. This compares to $69.1 million for the fiscal year ended June 30, 2015.
For the year ended June 30, 2016, the revenues from the management of the diagnostic imaging center segment, consisting of patient and management and other fee revenue, and less the provision for bad debt for patient revenue, increased 9% to $62.6 million as compared to $57.6 million one year earlier.
At June 30, 2016, total assets were $84.9 million, as compared to $76.5 million one year earlier.
At June 30, 2016, total cash and cash equivalents were $8.5 million, as compared to $9.4 million one year earlier.
At June 30, 2016, total liabilities were $24.1 million, as compared to $25.7 million one year earlier.
At June 30, 2016, total current liabilities were $20.6 million, as compared to $18.8 million one year earlier.
Significant Events
On January 6, 2016, the Company reported that its subsidiary Health Management Company of America now manages Stand-Up MRI of Great Neck, located in Great Neck, New York, bringing the total number of HMCA-managed centers to 25, of which 18 are located in New York and seven (7) in Florida.
On February 11, 2016, Timothy R. Damadian, Dr. Damadian's son, became President and Chief Executive Officer of FONAR Corporation. Raymond V. Damadian, M.D., the founder of the Company, remains Chairman of the Board.
On June 30, 2016, Health Management Company of America, of which FONAR is the majority owner, purchased 100% of the equity in Turnkey Services of New York, LLC. Turnkey Services of New York, LLC, by way of several operating leases, had provided HMCA-managed MRI facilities in Bronx, NY, and Brooklyn, NY, with ancillary diagnostic imaging equipment.
Also on June 30, 2016, Health Management Company of America, of which FONAR is the majority owner, purchased 100% of the equity in TK2 Equipment Management, LLC. TK2 Equipment Management, LLC, by way of several operating leases, had provided ancillary diagnostic imaging equipment to an HMCA-managed facility in Queens, NY, and to an HMCA-owned facility in Ft. Lauderdale, FL.
In addition, on June 30, 2016, Health Management Company of America, which had held a 50%-equity in Yonkers Diagnostic Management Services, LLC, purchased the remaining 50%, making the Yonkers entity a wholly-owned subsidiary of Health Management Company of America.
Management Discussion
President and CEO Timothy R. Damadian said, "I am pleased with our six percent (6%) growth rate in net revenue and our eleven percent (11%) increase in income from operations during fiscal 2016. The three acquisitions will add to net income, thereby contributing to the financial stability of the Company. We will continue to seek additional opportunities consistent with our growth strategy."
Chairman of the Board Raymond V. Damadian, M.D. said, "I am grateful for the current state of the Company. Since Fiscal 2011, FONAR's revenues have grown 121 percent and we've been profitable every quarter. As Timothy continues to execute his proven business strategy, I am confident of a favorable future for patients, employees and shareholders."
About FONAR
FONAR, The Inventor of MR Scanning ™, is located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ Imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often detects patient problems that other MRI scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.
FONAR has new works-in-progress technology for visualizing and quantifying the flow of cerebrospinal fluid (CSF) which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.
FONAR's substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. FONAR's UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™ , Full Range of Motion™, Multi-Position™ , Upright Radiology™, The Proof is in the Picture™ , True Flow™, pMRI™ , Spondylography™, Dynamic™ , Spondylometry™, CSP™ , and Landscape™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
| FONAR CORPORATION AND SUBSIDIARIES | ||||||
| CONSOLIDATED BALANCE SHEETS | ||||||
| ASSETS | ||||||
| June 30, | ||||||
| 2016 | 2015 | |||||
| Current Assets: | ||||||
| Cash and cash equivalents | $ | 8,528,309 | $ | 9,448,798 | ||
| Accounts receivable - net of allowances for doubtful accounts of $284,279 and $362,362 at June 30, 2016 and 2015, respectively | 4,370,155 | 3,790,981 | ||||
| Medical receivables - net of allowances for doubtful accounts of $17,451,782 and $15,459,156 at June 30, 2016 and 2015, respectively | 10,126,397 | 9,082,319 | ||||
| Management and other fees receivable - net of allowances for doubtful accounts of $13,069,702 and $13,271,651 at June 30, 2016 and 2015, respectively | 15,637,831 | 14,057,962 | ||||
| Management and other fees receivable - related party medical practices - net of allowances for doubtful accounts of $393,047 and $403,047 at June 30, 2016 and 2015, respectively | 4,063,539 | 3,507,204 | ||||
| Costs and estimated earnings in excess of billings on uncompleted contracts | - | 681,660 | ||||
| Inventories | 2,074,300 | 2,191,849 | ||||
| Prepaid expenses and other current assets | 759,042 | 860,040 | ||||
| Total Current Assets | 45,559,573 | 43,620,813 | ||||
| Deferred income tax asset | 13,042,360 | 8,423,306 | ||||
| Property and Equipment - Net | 14,512,706 | 12,901,195 | ||||
| Goodwill | 3,322,158 | 1,767,098 | ||||
| Other Intangible Assets - Net | 7,719,358 | 8,950,160 | ||||
| Other Assets | 731,451 | 829,505 | ||||
| Total Assets | $ | 84,887,606 | $ | 76,492,077 | ||
| FONAR CORPORATION AND SUBSIDIARIES | ||||||
| CONSOLIDATED BALANCE SHEETS | ||||||
| LIABILITIES | ||||||
| June 30, | ||||||
| 2016 | 2015 | |||||
| Current Liabilities: | ||||||
| Current portion of long-term debt and capital leases | $ | 2,447,693 | $ | 2,490,146 | ||
| Accounts payable | 1,254,485 | 1,782,442 | ||||
| Other current liabilities | 10,826,793 | 8,252,633 | ||||
| Unearned revenue on service contracts | 4,678,914 | 4,187,401 | ||||
| Customer deposits | 1,198,739 | 1,937,813 | ||||
| Billings in excess of costs and estimated earnings on uncompleted contracts | 206,623 | 142,217 | ||||
| Total Current Liabilities | 20,613,247 | 18,792,652 | ||||
| Long-Term Liabilities: | ||||||
| Deferred income tax liability | 481,779 | 510,492 | ||||
| Due to related party medical practices | 245,041 | 236,920 | ||||
| Long-term debt and capital leases, less current portion | 2,059,236 | 5,699,302 | ||||
| Other liabilities | 711,996 | 469,198 | ||||
| Total Long-Term Liabilities | 3,498,052 | 6,915,912 | ||||
| Total Liabilities | 24,111,299 | 25,708,564 | ||||
| FONAR CORPORATION AND SUBSIDIARIES | ||||||||
| CONSOLIDATED BALANCE SHEETS | ||||||||
| STOCKHOLDERS' EQUITY | ||||||||
| June 30, | ||||||||
| 2016 | 2015 | |||||||
| Stockholders' Equity: | ||||||||
| Class A non-voting preferred stock $.0001 par value; 453,000 shares authorized at June 30, 2016 and 2015, 313,438 issued and outstanding at June 30, 2016 and 2015 | $ | 31 | $ | 31 | ||||
| Preferred stock $.001 par value; 567,000 shares authorized at June 30, 2016 and 2015, issued and outstanding - none | - | - | ||||||
| Common stock $.0001 par value; 8,500,000 shares authorized at June 30, 2016 and 2015, 6,062,809 and 6,062,483 issued at June 30, 2016 and 2015, respectively; 6,051,166 and 6,050,840 outstanding at June 30, 2016 and 2015, respectively | 607 | 607 | ||||||
| Class B convertible common stock (10 votes per share) $.0001 par value; 227,000 shares authorized at June 30, 2016 and 2015, 146 issued and outstanding at June 30, 2016 and 2015 | - | - | ||||||
| Class C common stock (25 votes per share) $.0001 par value; 567,000 shares authorized at June 30, 2016 and 2015, 382,513 issued and outstanding at June 30, 2016 and 2015 | 38 | 38 | ||||||
| Paid-in capital in excess of par value | 173,702,335 | 175,447,586 | ||||||
| Accumulated deficit | (120,624,010 | ) | (136,348,635 | ) | ||||
| Notes receivable from employee stockholders | (23,879 | ) | (31,495 | ) | ||||
| Treasury stock, at cost - 11,643 shares of common stock at June 30, 2016 and 2015 | (675,390 | ) | (675,390 | ) | ||||
| Total Fonar Corporation's Stockholders' Equity | 52,379,732 | 38,392,742 | ||||||
| Noncontrolling interests | 8,396,575 | 12,390,771 | ||||||
| Total Stockholders' Equity | 60,776,307 | 50,783,513 | ||||||
| Total Liabilities and Stockholders' Equity | $ | 84,887,606 | $ | 76,492,077 | ||||
| FONAR CORPORATION AND SUBSIDIARIES | ||||||||||||
| CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||
| For the Years Ended June 30, | ||||||||||||
| 2016 | 2015 | 2014 | ||||||||||
| Revenues | ||||||||||||
| Product sales - net | $ | 1,276,882 | $ | 1,820,979 | $ | 1,877,932 | ||||||
| Service and repair fees - net | 9,396,736 | 9,549,316 | 10,082,631 | |||||||||
| Service and repair fees - related parties - net | 110,000 | 110,000 | 110,000 | |||||||||
| Patient fee revenue, net of contractual allowances and discounts | 32,985,809 | 28,153,598 | 24,307,192 | |||||||||
| Provision for bad debts for patient fee | (14,539,786 | ) | (12,770,249 | ) | (10,333,082 | ) | ||||||
| Management and other fees - net | 36,633,230 | 34,805,627 | 34,839,969 | |||||||||
| Management and other fees - related party medical practices - net | 7,505,339 | 7,381,725 | 7,620,835 | |||||||||
| Total Revenues - Net | 73,368,210 | 69,050,996 | 68,505,477 | |||||||||
| Costs and Expenses | ||||||||||||
| Costs related to product sales | 1,254,328 | 1,882,230 | 1,067,120 | |||||||||
| Costs related to service and repair fees | 2,148,143 | 2,189,373 | 2,496,985 | |||||||||
| Costs related to service and repair fees - related parties | 25,147 | 25,220 | 27,242 | |||||||||
| Costs related to patient fee revenue | 9,418,935 | 7,939,524 | 7,670,484 | |||||||||
| Costs related to management and other fees | 21,949,583 | 20,970,116 | 20,851,065 | |||||||||
| Costs related to management and other fees - related party medical practices | 4,074,762 | 5,397,818 | 5,134,553 | |||||||||
| Research and development | 1,631,846 | 1,812,398 | 1,760,821 | |||||||||
| Selling, general and administrative, inclusive of compensatory element of stock issuances of $2,006, $53,200 and $223,000 for the years ended June 30, 2016, 2015 and 2014, respectively | 18,711,799 | 13,459,408 | 15,388,239 | |||||||||
| Provision for bad debts | (201,949 | ) | 2,475,032 | 1,806,299 | ||||||||
| Total Costs and Expenses | 59,012,594 | 56,151,119 | 56,202,808 | |||||||||
| Income from Operations | 14,355,616 | 12,899,877 | 12,302,669 | |||||||||
| Other Income and (Expenses): | ||||||||||||
| Interest expense | (262,193 | ) | (702,095 | ) | (884,541 | ) | ||||||
| Investment income | 224,263 | 225,270 | 238,928 | |||||||||
| Other income (expense) - net | 190,560 | 394,810 | (608,599 | ) | ||||||||
| Income before benefit for income taxes and noncontrolling interests | 14,508,246 | 12,817,862 | 11,048,457 | |||||||||
| Benefit for Income Taxes | 4,287,271 | 2,612,521 | 2,348,312 | |||||||||
| Net Income | $ | 18,795,517 | $ | 15,430,383 | $ | 13,396,769 | ||||||
| Net Income - Noncontrolling Interests | (3,070,892 | ) | (2,519,732 | ) | (3,000,639 | ) | ||||||
| Net Income - Attributable to FONAR | $ | 15,724,625 | $ | 12,910,651 | $ | 10,396,130 | ||||||
| FONAR CORPORATION AND SUBSIDIARIES | |||||||||
| CONSOLIDATED STATEMENTS OF INCOME (Continued) | |||||||||
| For the Years Ended June 30, | |||||||||
| 2016 | 2015 | 2014 | |||||||
| Net Income Available to Common Stockholders | $ | 14,702,834 | $ | 12,071,670 | $ | 9,720,030 | |||
| Net Income Available to Class A Non-Voting Preferred Stockholders | $ | 761,561 | $ | 625,309 | $ | 503,911 | |||
| Net Income Available to Class C Common Stockholders | $ | 260,230 | $ | 213,672 | $ | 172,189 | |||
| Basic Net Income Per Common Share Available to Common Stockholders | $ | 2.43 | $ | 2.00 | $ | 1.62 | |||
| Diluted Net Income Per Common Share Available to Common Stockholders | $ | 2.38 | $ | 1.95 | $ | 1.58 | |||
| Basic and Diluted Income Per Share - Common C | $ | 0.68 | $ | 0.56 | $ | 0.45 | |||
| Weighted Average Basic Shares Outstanding - Common Stockholders | 6,050,893 | 6,050,632 | 6,009,822 | ||||||
| Weighted Average Diluted Shares Outstanding - Common Stockholders | 6,178,397 | 6,178,136 | 6,137,326 | ||||||
| Weighted Average Basic and Diluted Shares Outstanding - Class C Common | 382,513 | 382,513 | 382,513 | ||||||
Contact: Daniel Culver Director of Communications E-mail: Email Contact www.fonar.com Melville, New York 11747 Phone: (631) 694-2929
